Here are what the editors at HealthDay consider to be the most important developments in Internal Medicine for December 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Long-Term Reduction in CRC Risk After Negative Colonoscopy
MONDAY, Dec. 31, 2018 (HealthDay News) — For average-risk patients, a negative colonoscopy result is associated with a long-term reduction in the risk for colorectal cancer and related deaths, according to a study published online Dec. 17 in JAMA Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Incidence of End-Stage Kidney Disease Up in Australia
MONDAY, Dec. 31, 2018 (HealthDay News) — For nonindigenous people with type 2 diabetes mellitus (T2DM) in Australia, the age-standardized incidence of end-stage kidney disease (ESKD) increased from 2002 to 2013, according to a study published online Dec. 19 in the American Journal of Kidney Diseases.
Abstract/Full Text (subscription or payment may be required)
Catheter Ablation Tops Drug Therapy for A-Fib in Heart Failure
MONDAY, Dec. 31, 2018 (HealthDay News) — Catheter ablation is better than drug therapy for the treatment of atrial fibrillation (AF) in patients with heart failure, according to a review published online Dec. 25 in the Annals of Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Nurse-Led Program in Primary Care Can Up Detection of Liver Dz
MONDAY, Dec. 31, 2018 (HealthDay News) — A nurse-led primary care intervention can increase the number of new diagnoses of liver disease, according to a study published online Dec. 21 in PLOS ONE.
Effect Sizes Uncertain for Meds Versus Placebo in Knee OA
FRIDAY, Dec. 28, 2018 (HealthDay News) — For patients with knee osteoarthritis and at least 12 months of follow-up, there is uncertainty around estimates of effect size for the change in pain in association with medications versus placebo, according to a meta-analysis published in the Dec. 25 issue of the Journal of the American Medical Association.
Abstract/Full Text (subscription or payment may be required)
Second-Line Antidiabetic Meds May Impact Cardiovascular Risk
FRIDAY, Dec. 28, 2018 (HealthDay News) — For adults with type 2 diabetes initiating second-line antidiabetic medications (ADM), cardiovascular risk is increased with use of sulfonylureas or basal insulin versus newer ADM classes, according to a study published online Dec. 21 in JAMA Network Open.
High Sodium Intake Associated With New Atrial Fibrillation
FRIDAY, Dec. 28, 2018 (HealthDay News) — Sodium intake is associated with the long-term risk of new-onset atrial fibrillation (AF), according to a study recently published in the Annals of Medicine.
Sugar-Sweetened Drinks Linked to Chronic Kidney Disease Risk
Dobbs Decision Has Negatively Impacted Access to OB/GYN Practitioners 
Adults Prefer Messages Written by AI in Communication With Doctors 
Incidence of Suicide Higher for Female Physicians Than Nonphysicians 
Complications, Mortality Up With Surgery Immediately Preceding Weekend 
Adenotonsillectomy Tied to Lower Health Care Use in Pediatric Sleep Disordered Breathing 
Length of Stay After Lung Cancer Surgery Longer With Wildfire in County of Treating Facility 
Intraoperative Remifentanil, Sufentanil Tied to Poor Postoperative Pain Experience 
No Link Seen Between Preop GLP-1 Receptor Agonist Use and Postop Aspiration Pneumonia 
